Top

Reactions Weekly

Published in:

01-05-2022 | Cancer Biomarker | Case report

Abemaciclib/denosumab/fulvestrant

Diarrhoea and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Aoyagi H, et al. [A Case of Disseminated Myelocarcinoma with Bone Metastasis 15 Years after Mastectomy and Relatively Long-Term Survival through Multidisciplinary Treatment]. [Japanese]. Gan to Kagaku Ryoho 48: 1592-1594, No. 13, Dec 2021. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/35046266/ [Japanese; summarised from a translation]

Title: Abemaciclib/denosumab/fulvestrant
Diarrhoea and lack of efficacy: case report
Publication date: 01-05-2022
Publisher: Springer International Publishing
Keywords: Cancer Biomarker
Diarrhea
Bone Metastasis
Diarrhea
Denosumab
Fulvestrant
Denosumab
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-15743-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abemaciclib/denosumab/fulvestrant

Diarrhoea and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Multiple drugs

Idarubicin

Multiple drugs

Multiple drugs

Posaconazole

Doxorubicin